Unlock instant, AI-driven research and patent intelligence for your innovation.

Pyridostigmine bromide syrup and preparation method thereof

A technology of pyridostigmine bromide and syrup, which is applied in the field of medicine, can solve problems such as susceptibility to diabetes, inattention, and decreased digestive function, and achieve the effect of ensuring quality stability, clear and transparent products, and easy swallowing and taking

Inactive Publication Date: 2018-03-30
CHENGDU MEDICAL COLLEGE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in order to ensure the quality stability of the product, the current clinical syrups usually require high sucrose concentration. However, the use of high concentration sucrose has obvious health risks: eating too much sugar is prone to diabetes, hyperlipidemia, obesity, etc.; Too much sugar for children can easily lead to decreased digestive function, loss of appetite, and nutritional deficiencies that affect development. It can also increase adrenaline levels, cause anxiety, lack of concentration, and make children overly sensitive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyridostigmine bromide syrup and preparation method thereof
  • Pyridostigmine bromide syrup and preparation method thereof
  • Pyridostigmine bromide syrup and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] The preparation of embodiment 1 pyridostigmine bromide syrup of the present invention

[0028] 1. Preparation of 80% (g / mL) sucrose simple syrup: Weigh sucrose and add freshly prepared sterilized water, place in a water bath at 90°C, stir quickly with a glass rod until fully dissolved, wait for it to cool to room temperature, and mix evenly by ultrasonic , that is. Store in a refrigerator at 4°C and dilute with water when used.

[0029] 2. Preparation of 20% (g / mL) sodium benzoate solution and 20% (g / mL) citric acid solution: weigh sodium benzoate, add fresh sterilized water, fully dissolve, add water to the mark, and dilute to 20% Sodium benzoate solution. A 20% citric acid solution was prepared in the same way, and the two were prepared and stored at 4°C for future use.

[0030] 3. Preparation of pyridostigmine bromide syrup: Accurately weigh 7.5 g of PB (pyridostigmine bromide) crude drug in a beaker, add water to dissolve, add water to make up to 25 mL.

[0031]...

Embodiment 2

[0033] The screening of embodiment 2 auxiliary material of the present invention

[0034] 1. Preparation of stock solutions of various excipients

[0035] 1. Preparation of pyridostigmine stock solution: Weigh 7.5g of pyridostigmine crude drug, accurately weigh it, put it in a 25ml sterilized volumetric flask, add an appropriate amount of newly prepared sterilized water to dissolve, add water to the mark, and set Allow. The final concentration is 300mg / ml.

[0036] 2. Preparation of simple syrup: Weigh 400.0g of sucrose into a 500ml sterilized beaker, add an appropriate amount of freshly prepared sterilized water, place in a water bath at 90°C, stir quickly with a glass rod until fully dissolved, and transfer to a 500ml volumetric flask , wait for it to cool to room temperature, add water to dilute the scale mark, and ultrasonically mix to obtain 80% (g / ml) simple syrup, and its relative density (25° C.) is measured to be 1.308, which meets the requirements.

[0037] 3. The...

experiment example 1

[0067] Experimental example 1 stability experiment of pyridostigmine bromide syrup of the present invention

[0068] The syrup prepared according to Example 1 was placed at 4°C for 6 months, and its stability was investigated from aspects such as appearance, pH, and content. The results are shown in Table 1:

[0069] time

[0070] Experimental results: After the pyridostigmine bromide syrup of the present invention was placed at 4°C for 6 months, it became clear and transparent, and the appearance, color, pH and content of the main drug did not change significantly, indicating that its quality was stable.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses pyridostigmine bromide syrup. The pyridostigmine bromide syrup is prepared from, by massic volume, 1.20% of pyridostigmine bromide, 30-65% of saccharose, 0.15-0.30% of corrosion remover and 0.10-0.20% of pH regulator. The pyridostigmine bromide is prepared into the syrup, a patient can take the pyridostigmine bromide syrup conveniently, the patient can control the dosage byhimself, and the compliance of the patient, particularly a child patient is improved. Due to the fact that the pyridostigmine bromide syrup is successfully developed, a gap of domestic and oversea research and clinic application is filled, and the pyridostigmine bromide syrup has the great clinical significance and the wide application prospect.

Description

technical field [0001] The invention relates to a pyridostigmine bromide syrup and a preparation method thereof, belonging to the field of medicine. Background technique [0002] Pyridostigmine bromide (PB, structure such as formula 1) is a cholinesterase inhibitor, which is mainly used clinically for myasthenia gravis, postoperative abdominal distention, urinary retention, and supraventricular tachycardia. Pyridostigmine bromide can inhibit the activity of cholinesterase, reduce the destruction of acetylcholine released from cholinergic nerve endings, accumulate acetylcholine in the synaptic gap, and excitatory effects of muscarinic and nicotinic choline receptors occur, and It has a direct excitatory effect on the nicotinic choline receptor (N2 receptor) on the motor end plate, and can promote the release of acetylcholine from the motor nerve endings, thereby increasing the muscle tension of the gastrointestinal tract, bronchial smooth muscle and skeletal muscle of the who...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/08A61K47/26A61K47/12A61K31/4425A61P21/04A61P7/10A61P9/06
CPCA61K9/0095A61K31/4425A61K47/12A61K47/26
Inventor 高秀容许小红晏祺张燕张旭杨恒博
Owner CHENGDU MEDICAL COLLEGE